Feist-Weiller Cancer Center at LSUHSC-Shreveport
Oncology
Dr. Glenn M. Mills, MD
|
|
Give Review
Glenn Mills practices Oncology. He attended University of Mississippi School of Medicine. Dr. Glenn M. Mills is a published physician. He published 27 publications, including: 'Private Payer's Status Improves Male Breast Cancer Survival.' Dr. Glenn M. Mills accepts all Medicare patients.
Publications
- Private Payer's Status Improves Male Breast Cancer Survival.
- The prognostic utility of (18)F-FDG-PET metabolic tumor response after chemoradiotherapy for locally advanced head and neck Cancer.
- Improvements in Survival and Disparities for Advanced-Stage Laryngeal Cancer.
- Autologous transplantation as consolidation for aggressive non-Hodgkin's Lymphoma.
- Commercial Insurance Triples Chances of Breast Cancer Survival in a Public Hospital.
- Extended survival after chemotherapy and conservative radiotherapy for HPV-16 positive stage IVB oropharyngeal carcinoma.
- Lifestyle modification in colorectal Cancer patients: an integrative oncology approach.
- Chemoradiotherapy for unresectable stage IVB head and neck Cancer.
- ColoRectal Chemoprevention Pilot Study (SWOG-9041), randomized and placebo controlled: the importance of multiple luminal lesions.
- Phase II Evaluation of Early Oral Estramustine, Oral Etoposide, and Intravenous Paclitaxel Combined With Hormonal Therapy in Patients With High-risk Metastatic Prostat...
- Pharmacodynamic evaluation of temsirolimus in patients with newly diagnosed advanced-stage head and neck squamous cell carcinoma.
- Docetaxel, cisplatin, and fluorouracil induction chemotherapy followed by accelerated fractionation/concomitant boost radiation and concurrent cisplatin in patients wi...
- Metastatic malignant melanoma in a patient with Hodgkin's Lymphoma in remission.
- Phase 1-2a multicenter dose-ranging study of canfosfamide in combination with carboplatin and paclitaxel as first-line therapy for patients with advanced non-small cel...
- Phase II study of gemcitabine and cisplatin in patients with previously untreated extensive stage small cell lung Cancer: Southwest Oncology Group Study 9718.
- A gut reaction?
- Treatment of elderly non-small cell lung Cancer patients with three different schedules of weekly paclitaxel in combination with carboplatin: subanalysis of a randomiz...
- Head and neck Cancer with simultaneous lung Cancer.
- Adenoma recurrences after resection of coloRectal carcinoma: results from the Southwest Oncology Group 9041 calcium chemoprevention pilot study.
- Intratumoral cisplatin/epinephrine gel in advanced head and neck Cancer: a multicenter, randomized, double-blind, phase III study in North America.
- Multicenter, randomized trial for stage IIIB or IV non-small-cell lung Cancer using weekly paclitaxel and carboplatin followed by maintenance weekly paclitaxel or obse...
- Positive response of advanced oropharyngeal Cancer with trismus to chemoradiation.
- The role of intratumoral therapy with cisplatin/epinephrine injectable gel in the management of advanced squamous cell carcinoma of the head and neck.
- Induction chemotherapy followed by concomitant chemoradiation-induced regression of advanced cervical lymphadenopathy in head and neck Cancer as a predictor of outcome.
- Maintenance therapy with alternate-day prednisone improves survival in multiple myeloma patients.
- Cisplatin, cetuximab, and radiation in locally advanced head and neck squamous cell Cancer: a retrospective review.
Schools
Univ Of Ms Sch Of Med
Tripler Army Med Center
Brooke Amc
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Education
-
San Antonio Uniformed Services Health Education Consortium -
Tripler Army Medical Center -
University of Mississippi School of Medicine
Hospital
-
University Health Shreveport
Drug Facts
| NPI NUMBER | 1174543177 | |
| NPPES Provider LastName | MILLS | |
| NPPES Provider FirstName | GLENN | |
| NPPES Provider ZIPCode | 711034228 | |
| NPPES Provider State | LA | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 260.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 13.0 | |
| Percent Opioid Claims | 5.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1174543177 |
| Last Name Of The Provider | MILLS |
| First Name Of The Provider | GLENN |
| View All |
Similar Doctors
|
|
Dr. Reinhold Munker, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Robert A. Nickelson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Prakash Peddi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Vikas Dembla, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Philip A. Haddad, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Srinivas S. Devarakonda, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Maxwell C. McDonald III, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Johnny Craig, MD |
|
|
Dr. Penny L. Heinrich, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joyce E. Feagin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ashish D. Dwary, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Charles J. Paine, MD |
|
|
Dr. John P. Ponugupati, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kamran Shahid, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tannaz Armaghany, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dushyant Verma, MD
This Doctor is OpenDoctor Recommended.
|